ADAR1 Capital Management, LLC

Position in PCVX — Vaxcyte, Inc.

CIK 1940272 AUSTIN, TX

Position in PCVX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$8,488,956

-$6,569,495 QoQ

Shares Held

146,034

-43.6% QoQ

Ownership

0.098%

of shares outstanding

% of Portfolio

0.41%

of 13F equity value

Holder Rank

#86

of 329 holders

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ADAR1 Capital Management, LLC holds $1,760,528,411 across 192 Biotechnology names. PCVX ranks #49 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	1,804,703	$240,494,721
2	PTGX	Protagonist Therapeutics, Inc	960,863	$117,782,586
3	ROIV	Roivant Sciences Ltd.	3,157,008	$111,726,513
4	IMVT	Immunovant, Inc.	2,330,716	$89,802,487
5	ZLAB	Zai Lab Ltd	3,369,034	$64,011,646
6	AGIO	Agios Pharmaceuticals, Inc.	1,288,053	$47,799,646
7	CRNX	Crinetics Pharmaceuticals, Inc.	1,222,080	$45,730,233
8	CYTK	Cytokinetics Inc	457,907	$39,009,097

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,488,956	146,034	-43.6%	Shares	Sole	2026-08-14
2026-03-31	$15,058,451	259,137	-17.9%	Shares	Sole	2026-05-18
2025-12-31	$14,563,721	315,642	+48.1%	Shares	Sole	2026-02-18
2025-09-30	$7,674,565	213,064	+117.3%	Shares	Sole	2025-11-14
2025-06-30	$3,187,020	98,032	+665.9%	Shares	Sole	2025-08-14
2025-03-31	$483,328	12,800	+26.8%	Shares	Sole	2025-05-15
2024-09-30	$1,153,784	10,097	-17.6%	Shares	Sole	2024-11-14
2024-06-30	$924,997	12,250	+512.5%	Shares	Sole	2024-08-13
2024-03-31	$136,620	2,000	+1900.0%	Shares	Sole	2024-05-15
2023-12-31	$6,280	100	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.